• Facebook
  • Rss
  • Twitter
  • Youtube
  • Store
  • Donate
  • 0Shopping Cart
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • COVID-19 Resources for Cancer Survivors
    • Order Our Resources
  • News
    • Cancer Convos Podcast
  • Events
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us
  • Search
  • Menu Menu

Year-End MATCH (DEADLINE Dec 31): Donate & Make a Difference | Donate

Second Anniversary of State Exchanges: Affordable Options for Cancer Patients, But the Devil Remains in the Details

January 30, 2015/in Cancer News, Cancer Policy Blog Access to Care, Affordable Care Act NCCS News /by actualize

Cancer Policy Matters Guest Post by Tanisha Carino, Executive Vice President, Avalere Health

Tanisha Carino

Guest Blog Post by Tanisha Carino, Avalere Health

Just one year after the launch of the state exchanges, we have seen a remarkable drop in the number of Americans without health insurance. By the end of 2015, Avalere projects 10.5 million people will be enrolled in the exchanges, which will result in fewer uninsured Americans. For individuals with cancer and their family members, affordable insurance options are essential to ensuring financial security and maintaining peace of mind.

However, in order to understand what the state exchange market means to individuals, the devil is in the details.

  • The vast majority of cancer patients seeking coverage in the exchanges will benefit from lower costs due to subsidies. As of January 16, 2015, 87 percent of individuals who had enrolled in exchange coverage for 2015 were eligible for financial assistance to lower their monthly premium. In addition, Avalere estimates that more than half of all exchange enrollees also qualify for cost-sharing reductions, which help to reduce out-of-pocket maximums and other service-related costs. These subsidies offer important protections for low-income cancer patients earning less than 250 percent of poverty.
  • Geography matters when it comes to maintaining affordable insurance options. In 2014, two-thirds of federal exchange consumers picked Silver plans and 43 percent picked the lowest-cost option. In 2015, we’ve seen a modest, average premium increase of 4 percent among lowest-cost Silver plans. However, these premiums vary widely by geography. For example, lowest-cost Silver premiums increased 28 percent on average in Alaska, while the same premiums decreased by 18 percent on average in New Hampshire.
  • Modest increases in premiums had to be balanced with higher upfront out-of-pocket costs. Average deductibles are higher in 2015 compared to 2014. In 2014, many insurance carriers designed benefits with high deductibles to meet the actuarial value targets set forth in the law. In 2015, deductibles increased steadily, with the average deductible for Silver plans jumping 7 percent to $2,658. Deductible increases varied by metal level, with Bronze, Gold, and Platinum deductibles growing 4, 6, and 23 percent respectively between 2014 and 2015.
  • Cancer patients seeking treatment will experience a greater use of coinsurance for specialty medications. The advent of plans charging coinsurance greater than 30 percent for specialty medications has increased from 27 percent of Silver plans in 2014 to 41 percent in 2015. Overall, 80 percent of Silver plans use coinsurance for products placed on the specialty tier. In comparison, 91 percent of Bronze, 80 percent of Gold, and 66 percent of Platinum plans charge coinsurance for specialty medications. Higher coinsurance rates make it more challenging for consumers to access care, which in turn, enhances the value of their cost sharing subsidies to mitigate costs.
20 Years Later

Read more posts from our “20 Years Later” series.

Overall, state exchanges are offering affordable options. Still, individuals with cancer and their families should look closely at whether lower monthly premiums, in exchange for high out-of-pocket costs fit their individual circumstance or whether choosing a plan with higher premiums, but more generous coverage makes better sense in the long run. Understanding the complexities of these tradeoffs can be difficult, and emphasizes the need for more sophisticated consumer support tools that allow individuals to tailor their plan choice to their particular needs. For example, in Minnesota the exchange portal prompts users to answer a series of questions about their expected health needs over the next year, allowing them to better gauge expenses by metal level and deductible amount. Consumers are also able to search for plan options that include certain wellness programs, and in the near future, the state will launch a more robust provider search tool, giving consumers up-to-date information on in-network providers. These support tools empower individuals to make more informed decisions when selecting coverage, and help individuals to better understand critical information relating to their healthcare coverage.

Looking ahead, outstanding questions persist regarding whether provider networks in the exchange market include top cancer centers. This is particularly important for individuals looking to participate in clinical trials, and in 2015, we expect that network adequacy standards will emerge as a top priority for policymakers.

Finally, in early March, attention will undoubtedly shift to the Supreme Court as it considers the legality of providing subsidies to consumers enrolled in the federal exchange. A ruling against the Administration could set in motion a significant restructuring of the Affordable Care Act, which would change the exchange landscape for years to come.

Tanisha Carino, Executive Vice President, oversees Avalere’s strategic advisory and research services for the nation’s leading life sciences companies. For close to a decade, Tanisha has worked with senior leadership in FORTUNE 500 companies to establish organizational goals and align their internal functions to capture opportunities and mitigate challenges related to evolving regulatory, evidence, and commercial trends. Follow Tanisha on Twitter: @tcarinoavalere.

About Avalere: Avalere Health is a strategic advisory company whose core purpose is to create innovative solutions to complex healthcare problems. Based in Washington, D.C., the firm delivers actionable insights, business intelligence tools and custom analytics for leaders in healthcare business and policy. Avalere’s experts span 180 staff drawn from Fortune 500 healthcare companies, the federal government (e.g., CMS, OMB, CBO and the Congress), top consultancies and nonprofits. Follow Avalere on Twitter: @avalerehealth. The views & opinions expressed in any guest post featured on our site are those of the guest author and do not necessarily reflect the opinions & views of the National Coalition for Cancer Survivorship. Read our blog and comment policies here.

Tags: 20 Years Later, affordable care act, cancer care, Cancer Survivorship, exchange plans, Guest Post, qualified health plans, quality
Share this entry
  • Share on Facebook
  • Share on Twitter
0 0 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2015-01-30 15:37:552015-01-30 15:37:55Second Anniversary of State Exchanges: Affordable Options for Cancer Patients, But the Devil Remains in the Details
You might also like
Remembering Kathryn West FI Remembering Kathryn West
FacebookProfile3 What effects the health care law has had and what’s to come
NCCS Communications Director The AHCA’s 52 Million Uninsured Is Not “Freedom”
Palliative Care and Living Well with Cancer Focus on the Care Video: Palliative Care and Living Well with Cancer
NCCS Starburst 250px Health Care Roundup: Insights on Telehealth, Decline in Medical Visits, Standards of Care, and More
Ellen Goodman Acceptance Speech Cancer Patients Should Be Wary of Needless Tests and Treatments
Zanartu Help Hurt Tool Physician Guest Blog: Improving How Doctors and Patients Have Difficult Conversations
Ellen Goodman Acceptance Speech Celebrating the 2015 NCCS Focus on the Care Honorees in Pictures and Video

Latest News

HHS Humphrey bldg 1200

NCCS, Cancer Groups Urge CMS to Withdraw Most Favored Nation (MFN) Medicare Part B Rule That Will Harm Patients and Reduce Access to Care

December 22, 2020
The National Coalition for Cancer Survivorship (NCCS) joined other member organizations…
Read more
https://canceradvocacy.org/wp-content/uploads/2017/10/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-22 20:27:262021-01-04 21:38:15NCCS, Cancer Groups Urge CMS to Withdraw Most Favored Nation (MFN) Medicare Part B Rule That Will Harm Patients and Reduce Access to Care
NCCS Letter to HHS

NCCS Letter to HHS: Proposed Regulatory Review Rule Would Create Unnecessary Uncertainty for Patients

December 9, 2020
The National Coalition for Cancer Survivorship (NCCS) recently submitted comments…
Read more
https://canceradvocacy.org/wp-content/uploads/HHS-Humphrey-bldg-1200-1030x515-1.jpg 515 1030 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-09 17:30:502020-12-10 08:22:55NCCS Letter to HHS: Proposed Regulatory Review Rule Would Create Unnecessary Uncertainty for Patients
HHS Humphrey bldg 1200

NCCS Opposes Most Favored Nation (MFN) Rule: New Medicare Part B Drug Payment Model Will Harm Patients

December 3, 2020
The National Coalition for Cancer Survivorship (NCCS) opposes the Most Favored Nation…
Read more
https://canceradvocacy.org/wp-content/uploads/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2020-12-03 21:26:462020-12-03 21:28:06NCCS Opposes Most Favored Nation (MFN) Rule: New Medicare Part B Drug Payment Model Will Harm Patients

Take Action

Stovall Award

The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • COVID-19 Resources for Cancer Survivors
    • Order Our Resources
  • News
    • Cancer Convos Podcast
  • Events
    • Ellen L. Stovall Award
      • 2020 Stovall Awards
      • Honorees
      • Sponsors
      • Committees
      • Reception
      • Nominations
    • Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

NCCS Joins Colleagues in Submitting Comments to NIH on the Use of a Single Institutional... Dome Thumbnail starburst NCCS Starburst Thumbnail WCOE: Obama takes on Precision Medicine, Palliative Care ≠ Hospice, Quantity...
Scroll to top

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute